Dr. Jeremy Segal, MD, PhD - Assistant Professor of Pathology; Director of Molecular and Cytogenetic Pathology; President of the Genomics Organization for Academic Laboratories (GOAL)

In this first webinar, we will cover various applications for NGS and different aspects of comprehensive genomic tests, including variants, CNVs, rearrangements, MSI, mutational signatures, TMB, and more. Additionally, we will briefly touch on different types of tests such as ctDNA and MRD to provide a sense of the testing landscape.

OCT 17, 2024 8:15 AM PDT

Andrea Gaedigk, PhD - Director Pharmacogenetic Core Laboratory, Division of Clinical Pharmacology and Therapeutic Innovation

Wendy Wang - Researcher and Laboratory Supervisor Pharmacogenomics Children's Mercy Research Institute, Department of Clinical Pharmacology and Toxicology

Accurate prediction of CYP2D6 activity from genotype data is of utmost importance as CYP2D6 pharmacogenetic (PGx) testing is increasingly used to guide drug therapy. However, given the complexity of the highly polymorphic CYP2D6 gene locus, PGx testing is not trivial and presents considerable challenges especially regarding copy number testing to capture the many structural variants. In this ...

OCT 21, 2024 9:00 PM PDT

Andrea Gaedigk, PhD - Director Pharmacogenetic Core Laboratory, Division of Clinical Pharmacology and Therapeutic Innovation

Wendy Wang - Researcher and Laboratory Supervisor Pharmacogenomics Children's Mercy Research Institute, Department of Clinical Pharmacology and Toxicology

Accurate prediction of CYP2D6 activity from genotype data is of utmost importance as CYP2D6 pharmacogenetic (PGx) testing is increasingly used to guide drug therapy. However, given the complexity of the highly polymorphic CYP2D6 gene locus, PGx testing is not trivial and presents considerable challenges especially regarding copy number testing to capture the many structural variants. In this ...

OCT 22, 2024 10:00 AM CEST

Andrea Gaedigk, PhD - Director Pharmacogenetic Core Laboratory, Division of Clinical Pharmacology and Therapeutic Innovation

Wendy Wang - Researcher and Laboratory Supervisor Pharmacogenomics Children's Mercy Research Institute, Department of Clinical Pharmacology and Toxicology

Accurate prediction of CYP2D6 activity from genotype data is of utmost importance as CYP2D6 pharmacogenetic (PGx) testing is increasingly used to guide drug therapy. However, given the complexity of the highly polymorphic CYP2D6 gene locus, PGx testing is not trivial and presents considerable challenges especially regarding copy number testing to capture the many structural variants. In this ...

OCT 22, 2024 10:00 AM PDT